Last reviewed · How we verify
PRO283698
At a glance
| Generic name | PRO283698 |
|---|---|
| Sponsor | Genentech, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRO283698 CI brief — competitive landscape report
- PRO283698 updates RSS · CI watch RSS
- Genentech, Inc. portfolio CI